Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II.

Literature DB >> 1651134

Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II.

J Pedersen-Bjergaard, P Philip.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1991 PMID： 1651134

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
Cited

× No keyword cloud information.

33 in total

1. Acute myeloid leukemia with t(11;19)(q23;p13) developing in an adult T-cell leukemia patient treated with combined chemotherapy including etoposide.

Authors: N Kanemura; H Tsurumi; T Hara; T Yamada; M Sawada; T Naito; H Moriwaki
Journal: Int J Hematol Date: 2001-12 Impact factor: 2.490

2. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.

Authors: M D Megonigal; E F Rappaport; D H Jones; C S Kim; P C Nowell; B J Lange; C A Felix
Journal: Proc Natl Acad Sci U S A Date: 1997-10-14 Impact factor: 11.205

3. Molecular characterization and clinical course of MLL-ACTN4 rearrangement in therapy-related hematologic malignancies.

Authors: John Jeongseok Yang; Tae Sung Park; Seung-Tae Lee; Ja-Young Seo; Seung Hwan Oh; Eun Hae Cho; Thomas Burmeister; Wolf-Dieter Ludwig; Claus Meyer; Rolf Marschalek; Hee-Jin Kim; Sun-Hee Kim
Journal: Haematologica Date: 2014-02-21 Impact factor: 9.941

Review 4. Therapy-related myeloid neoplasms - what have we learned so far?

Authors: Mohammad Faizan Zahid; Aric Parnes; Bipin N Savani; Mark R Litzow; Shahrukh K Hashmi
Journal: World J Stem Cells Date: 2016-08-26 Impact factor: 5.326

5. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.

Authors: Jenny N Poynter; Michaela Richardson; Michelle Roesler; Cindy K Blair; Betsy Hirsch; Phuong Nguyen; Adina Cioc; James R Cerhan; Erica Warlick
Journal: Int J Cancer Date: 2016-09-24 Impact factor: 7.396

6. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.

Authors: M Stanulla; J Wang; D S Chervinsky; S Thandla; P D Aplan
Journal: Mol Cell Biol Date: 1997-07 Impact factor: 4.272

Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II.

1. Acute myeloid leukemia with t(11;19)(q23;p13) developing in an adult T-cell leukemia patient treated with combined chemotherapy including etoposide.

2. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.

3. Molecular characterization and clinical course of MLL-ACTN4 rearrangement in therapy-related hematologic malignancies.

Review 4. Therapy-related myeloid neoplasms - what have we learned so far?

5. Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.

6. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis.

7. Therapy-related myelodysplasia and acute myeloid leukemia.

Review 8. Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.

9. Second cancers in patients with the Ewing sarcoma family of tumours.

10. The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cells.